@FiercePharma: Other compounded drugs may be tied into meningitis outbreak, FDA says. Another NECC steroid + NECC heart drug. More | Follow @FiercePharma
> Two more drugs sold by New England Compounding are suspected in the growing meningitis outbreak, which has so far killed 15 patients and sickened more than 200. Report | Report
> Three weeks after its U.S. patent expiration, Novartis ($NVS) has kept 69% of the market for Diovan HCT, a combination version of its hypertension drug, in part because of its own authorized generic version. Report
> Sanofi ($SNY) is expanding its Turkish operations to make a production plant in Luleburgaz a hub for antibiotics export to 40 countries. Report
> Novo Nordisk ($NVO) filed for regulatory approval of its new hemophilia treatment turoctocog alfa in Europe and the U.S. Report | Release
> Ireland's Jazz Pharmaceuticals said it wrapped up the sale of its women's health business to Sweden's Meda. Report
@FierceMedDev: JNJ pulled in $7.1 billion from medical devices and diagnostics in Q3, a 12.5% jump. More | Follow @FierceMedDev
@MarkHFierce: Patients in India thrived with used ICD implants. Can this be done on a broader scale? More | Follow @MarkHFierce
@DamianFierce: Medtronic is buying a $66.2M stake in China's LifeTech Scientific, makers of cardiovascular devices. More | Follow @DamianFierce
> Amid Dx sales growth, Roche Diagnostics considers another buy. News
> Lanx draws $8.7M for spinal fusion device development. Item
Biotech News
@FierceBiotech: New special report on FierceVaccines.com: 10 promising therapeutic vaccines in 2012. Feature | Follow @FierceBiotech
@JohnCFierce: Genzyme, $ISIS likely to get some tough safety questions on Kynamro at this week's FDA panel. More | Follow @JohnCFierce
@RyanMFierce: Piramal is poised to be a big consolidator in pharma services/manufacturing, but apparently only at the right price. More | Follow @RyanMFierce
> FDA frets over safety of Genzyme's rival drug for rare cholesterol disease. Article
> Bullish Roche talks targeted takeovers, showcases T-DM1's prospects. Story
> ArQule, Threshold get a bounce out of PhIII SPA pacts with FDA. Report
Biotech Research News
> NIH funds Advanced Cancer Therapeutics' preclinical brain cancer drug work. Report
> Scientists flee $3B Texas cancer research fund. Item
> Alnylam, Tel Aviv U develop RNAi drugs to fight rare blood cancer. Article
> Alzheimer's drug builds new brain cell connections in rats. News
> Scientists build neural-like stem cells from mouse muscle tissue. Story
Pharma Manufacturing News
> GSK cancels plans to close Stiefel plant in Ireland. Story
> Cinven continues generics deal spree with Amdipharm buy. Article
> Teva Pharma opens $110M plant in Hungary. News
> Analysis: Compounding groups fought FDA oversight before NECC disaster. Report
And Finally... A CVS Caremark unit agreed to pay $5.25 million to settle claims that it misrepresented prices of certain Medicare prescription drugs, the Department of Justice said. Report